NewJ.Chem., 2015 39, 1101-14.pdf (original) (raw)

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2018

Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking

Mariusz Jaremko

International Journal of Molecular Sciences, 2022

View PDFchevron_right

IDENTIFICATION OF ETHR INHIBITOR TARGETING MYCOBACTERIUM TUBERCULOSIS: AN INSIGHT FROM MOLECULAR DOCKING STUDY

Asian Journal of Pharmaceutical and Clinical Research Journal

Asian Journal of Pharmaceutical and Clinical Research Journal, 2022

View PDFchevron_right

Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents

Uttam More

View PDFchevron_right

Sm, Eu, Triply phenoxo NJC 2015, 39, 1101.pdf

Chittaranjan Sinha

View PDFchevron_right

Inorg. Chem. Front., 2015,.pdf

Chittaranjan Sinha

View PDFchevron_right

Molecular docking study of catechol-O-methyltrasferase inhibitor on enoyl acyl carrier protein reductase of mycobacterium tuberculosis

World Journal of Pharmaceutical Sciences

View PDFchevron_right

Slow-Onset Inhibition of 2-trans-Enoyl-ACP (CoA) Reductase from Mycobacterium tuberculosis by an Inorganic Complex

Jaime Oliveira

Current Pharmaceutical Design, 2006

View PDFchevron_right

Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

Robert Stroud

Journal of Medicinal Chemistry, 2006

View PDFchevron_right

A Ni(ii) dinuclear complex bridged by end-on azide-N and phenolate-O atoms: spectral interpretation, magnetism and biological study

Chittaranjan Sinha

Inorganic chemistry frontiers, 2015

View PDFchevron_right

Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors

Steven Sucheck, Sri Kumar Veleti

Scientific reports, 2015

View PDFchevron_right

Structure based Docking of Secondary Metabolites against DrpE1 to Treat Tuberculosis

IJRASET Publication

International Journal for Research in Applied Science and Engineering Technology IJRASET, 2020

View PDFchevron_right

Cu(II)-enolato bridged Coumarinyl New J. Chem., 2015, 39, 7309--7321.pdf

Chittaranjan Sinha

View PDFchevron_right

Specific interactions between 2-trans enoyl-acyl carrier protein reductase and its ligand: Protein-ligand docking and ab initio fragment molecular orbital calculations

Pharit Kamsri

Journal of Molecular Graphics and Modelling, 2019

View PDFchevron_right

Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis

Tarakanta Jana

Indian journal of biochemistry & biophysics, 2012

View PDFchevron_right

Research of new anti-tuberculosis agents by molecular docking's method

Abderrahmane Bensegueni

Journal of Computational Methods in Molecular Design, 2016

View PDFchevron_right

Synthesis and molecular docking of isonicotinohydrazide derivatives as anti-tuberculosis candidates

tresna lestari

Malaysian Journal of Fundamental and Applied Sciences

View PDFchevron_right

Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): A theoretical approach

Tamara Delaine

Journal of Molecular Graphics and Modelling, 2008

View PDFchevron_right

An analysis of docking study on tuberculosis inhibitors

Manoj Giri

International Journal, 2010

View PDFchevron_right

Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl- ACP(CoA) reductase enzyme OPEN

Osmar Norberto de Souza, Ivani Pauli

View PDFchevron_right

A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

Caroline Kisker

Journal of Biological Chemistry, 2010

View PDFchevron_right

Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides

Paul Ortiz de Montellano

Bioorganic & Medicinal Chemistry, 2007

View PDFchevron_right

Synthesis, characterization and in vitro extracellular and intracellular activity against Mycobacterium tuberculosis infection of new second-line antitubercular drug-palladium complexes

Morena Nocchetti, Stefano Giovagnoli

The Journal of pharmacy and pharmacology, 2014

View PDFchevron_right

Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme

Guilherme Petersen

Scientific reports, 2017

View PDFchevron_right

Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum

Fidele Ntie-Kang

Molecular Informatics, 2015

View PDFchevron_right

Synthesis, Characterization and In Silico Study of Fe(III) Complex with N'-(4-Chlorobenzoyl)-Isonicotino-Hydrazide as Anti Tuberculosis Candidate

Ruswanto Suharjo

Jurnal Kimia Valensi, 2020

View PDFchevron_right

An inorganic complex that inhibits Mycobacterium tuberculosis enoyl reductase as a prototype of a new class of chemotherapeutic agents to treat tuberculosis

Luiz Basso

Journal of the Brazilian Chemical Society, 2010

View PDFchevron_right

Docking Studies of N-alkylated Indole Derivatives with Mycobacterium Enoyl Acyl Carrier Protein Reductase (Inh A) as Potent Antitubercular Agents

Shivam Joshi

Oriental Journal Of Chemistry

View PDFchevron_right

Structure based screening of ligands against dTDP-6-deoxy-D- xylo-4-hexulose 3, 5-epimerase (RmlC): phytochemical as drug candidate for Mycobacterium tuberculosis

Pharmaceutical and Biological Evaluations

View PDFchevron_right

NewJ.Chem., 2015 39, 1101-14.pdf (original) (raw)

Related papers